Td Asset Management Inc Bio N Tech Se Transaction History

Td Asset Management Inc

$108 Billion
Q2 2025

A detailed history of Td Asset Management Inc transactions in Bio N Tech Se stock. As of the latest transaction made, Td Asset Management Inc holds 173,795 shares of BNTX stock, worth $18.6 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

173,795

Previous 11,452 1417.6%

Holding current value

$18.6 Million

Previous $1.04 Million 1675.72%

% of portfolio

0.02%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 28, 2025	BUY	$86.65 - $120.54 $14.1 Million - $19.6 Million	162,343 Added 1417.6%	173,795 $18.5 Million
Q1 2025 May 07, 2025	SELL	$91.06 - $126.88 $2.96 Million - $4.13 Million	-32,530 Reduced 73.96%	11,452 $1.04 Million
Q4 2024 Feb 11, 2025	SELL	$99.72 - $122.68 $15,755 - $19,383	-158 Reduced 0.36%	43,982 $5.01 Million
Q3 2024 Nov 01, 2024	BUY	$78.36 - $124.66 $2.86 Million - $4.56 Million	36,550 Added 481.55%	44,140 $5.24 Million
Q2 2024 Aug 02, 2024	BUY	$80.36 - $102.87 $34,956 - $44,748	435 Added 6.08%	7,590 $609,000
Q1 2024 May 08, 2024	BUY	$88.96 - $112.35 $636,508 - $803,864	7,155 New	7,155 $660,000
Q4 2022 Feb 06, 2023	SELL	$118.43 - $186.05 $3.79 Million - $5.96 Million	-32,035 Reduced 38.68%	50,786 $7.63 Million
Q3 2022 Nov 07, 2022	BUY	$127.65 - $183.11 $278,915 - $400,095	2,185 Added 2.71%	82,821 $11.1 Million
Q2 2022 Aug 04, 2022	SELL	$123.25 - $186.24 $2.99 Million - $4.51 Million	-24,223 Reduced 23.1%	80,636 $12 Million
Q1 2022 May 10, 2022	BUY	$126.25 - $231.85 $214,751 - $394,376	1,701 Added 1.65%	104,859 $17.9 Million
Q4 2021 Feb 10, 2022	BUY	$216.64 - $362.52 $5.15 Million - $8.61 Million	23,758 Added 29.92%	103,158 $26.6 Million
Q3 2021 Nov 09, 2021	SELL	$205.93 - $447.23 $13.9 Million - $30.1 Million	-67,355 Reduced 45.9%	79,400 $21.7 Million
Q2 2021 Aug 11, 2021	BUY	$113.32 - $241.49 $2.92 Million - $6.23 Million	25,784 Added 21.31%	146,755 $48.2 Million
Q1 2021 May 14, 2021	BUY	$85.73 - $119.5 $2.84 Million - $3.96 Million	33,106 Added 37.68%	120,971 $13.2 Million
Q4 2020 Feb 16, 2021	BUY	$72.71 - $129.54 $2.12 Million - $3.77 Million	29,100 Added 49.52%	87,865 $7.16 Million
Q3 2020 Nov 10, 2020	BUY	$57.81 - $104.17 $2.48 Million - $4.47 Million	42,865 Added 269.59%	58,765 $4.07 Million
Q2 2020 Aug 13, 2020	BUY	$38.58 - $66.74 $613,422 - $1.06 Million	15,900 New	15,900 $1.06 Million

Others Institutions Holding BNTX

# of Institutions

318

Shares Held

40.9M

Call Options Held

1.37M

Put Options Held

1.52M

View Full List

About BioNTech SE

Ticker BNTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 242,684,992
Market Cap $25.9B
Description
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...

More about BNTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Td Asset Management Inc with notifications on news.

Account

Td Asset Management Inc Bio N Tech Se Transaction History